ARCHIVES

Control AC Hear Report On High Risk conference, Messer Survey

This article is from The Cancer Letter archive.

Vol. 01 No. 31 | September 6, 1974

Download PDF Visit The Full Archive

Related Articles

FDA Approves Taxotere And Gemzar; Sends Approvable Letter For Etopophos

May 24, 1996

NCCN Also to Warn Doctors. Amgen’s Pledges to Disclose Future Results.

February 23, 2007

NCI Fund Grants To Increase Minority Internet Access.

October 6, 2000

Preclinical Models: NCI Advisors OK Plan For Mouse Models Consortium

March 13, 1998

Final Issue Of the Year

December 14, 1990

New Organ Systems Program Coordinating Center RFA Released

April 1, 1983